Author

Y.-J. Jang

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Microbiology· 1 Pharmacology & Toxicology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:host-pathogen & immune response· 2 Assay:metagenomics· 1 Organism:mouse· 1 Organism:rat· 1

Frequent Co-Authors

C. K. Min· 1 shared D. Jang· 1 shared D. Kim· 1 shared H. S. Choi· 1 shared I. Oh· 1 shared J. E. Kim· 1 shared J. Lee· 1 shared J. S. Moon· 1 shared

Activity by Year

2019-2023 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 20 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperPharmacology & Toxicology

C. K. Min

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Evaluation of purine-nucleoside degrading ability and in vivo uric acid lowering of Streptococcus thermophilus (ID-PDP3), a novel antiuricemia strain

D. Kim, J. S. Moon, J. E. Kim, Y.-J. Jang, H. S. Choi, I. Oh

This study evaluates the purine-nucleoside degrading ability and uric acid lowering effect of Streptococcus thermophilus IDCC 2201 in a rat model of hyperuricemia.

bioRxiv · Oct 12, 2023 · PreprintMicrobiology

GV1001 prevents ovarian follicle loss triggered by an anti-VEGF monoclonal antibody targeting non-small cell lung carcinoma xenografts in mice

D. Jang, M. Kim, C. K. Min, J. Lee, Y.-J. Jang, K. Hwang

This study shows that GV1001 reduces ovarian follicle loss caused by bevacizumab in mice without affecting its anti-cancer effects.

bioRxiv · Jul 30, 2019 · PreprintPharmacology & Toxicology